(Reuters) -Medical products maker Smith+Nephew maintained its 2025 outlook on Wednesday, despite anticipating a net impact of $15 million to $20 million from U.S. tariffs.
The company said it is working to mitigate the potential impact by leveraging its global manufacturing network, including adjustments to product mix and supply routes.
(Reporting by Yamini Kalia in Bengaluru; Editing by Sherry Jacob-Phillips)
Brought to you by www.srnnews.com
